comorbidity

You have access
Prescription Medications and Overall Survival in Metastatic Hormone Sensitive Prostate Cancer
CARLEY PICKETT, KRISHNY KARUNANANDAA, KAITLIN STACKABLE, DANIEL B. EATON, STEVEN TOHMASI, DEEPIKA GOPUKUMAR, VARUN PURI and MARTIN W. SCHOEN

Anticancer Research August 2024, 44 (8) 3443-3449; DOI: https://doi.org/10.21873/anticanres.17164
Open Access
Sociodemographic Barriers to the Timely Treatment of Pancreatic Cancer
PAOLA BERRIOS JIMENEZ, REED POPP, SEEMA SHARAN, HARSHEEN K. MANAISE, SYEDA HOORULAIN AHMED, SHIVAM BANSAL, GABRIELLE KOWKABANY, SWATHI RAIKOT, KULKAEW BELLE SUKNIAM DO, ANTHONY GEORGE and EMMANUEL GABRIEL

Anticancer Research November 2023, 43 (11) 4969-4974; DOI: https://doi.org/10.21873/anticanres.16695
You have access
Independent External Validation of the METSSS Model Predicting Survival After Palliative Radiotherapy
CARSTEN NIEDER, BARD MANNSÅKER and ROSALBA YOBUTA

Anticancer Research March 2022, 42 (3) 1477-1480; DOI: https://doi.org/10.21873/anticanres.15618
You have access
Treatment Contraindications Based on Comorbidity Status in Patients With Melanoma in the United States
DANIEL BOCZAR, SANJAY P. BAGARIA, AARON C. SPAULDING, MARIA T. HUAYLLANI, FRANCISCO R. AVILA, GUNEL GULIYEVA, XIAONA LU, BRIAN D. RINKER and ANTONIO J. FORTE

Anticancer Research April 2021, 41 (4) 2067-2070; DOI: https://doi.org/10.21873/anticanres.14976
You have access
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO and YASUHIRO SHIMADA

Anticancer Research April 2021, 41 (4) 2203-2207; DOI: https://doi.org/10.21873/anticanres.14996
You have access
Age Adjusted Charlson Comorbidity Index Strongly Influences Survival, Irrespective of Performance Status and Age, in Patients With Advanced Prostatic Cancer Treated With Enzalutamide
HENDRIK KAREL VAN HALTEREN and GERARD VREUGDENHIL

Anticancer Research February 2019, 39 (2) 863-866; DOI: https://doi.org/10.21873/anticanres.13186
You have access
Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy
GIUSEPPE L. BANNA, ANDREA CAMERINI, GIUSEPPE BRONTE, GIUSEPPE ANILE, ALFREDO ADDEO, FRANCESCO RUNDO, GUIDO ZANGHÌ, ROHIT LAL and MASSIMO LIBRA

Anticancer Research June 2018, 38 (6) 3689-3697; DOI: https://doi.org/10.21873/anticanres.12647
You have access
Safety of Laparoscopic Surgery for Colorectal Cancer in Patients with Severe Comorbidities
SHO SAWAZAKI, MASAKATSU NUMATA, JUNYA MORITA, YUKIO MAEZAWA, SHINYA AMANO, TORU AOYAMA, HIROSHI TAMAGAWA, TSUTOMU SATO, TAKASHI OSHIMA, HIROYUKI MUSHIAKE, NORIO YUKAWA, MANABU SHIOZAWA, YASUSHI RINO and MUNETAKA MASUDA

Anticancer Research June 2018, 38 (6) 3767-3772; DOI: https://doi.org/10.21873/anticanres.12659
You have access
Outcome of Trimodal Therapy in Elderly Patients with Esophageal Cancer: Prognostic Value of the Charlson Comorbidity Index
DANIELE BERNARDI, EMANUELE ASTI, ALBERTO AIOLFI, GIANLUCA BONITTA, ALBERTO LUPORINI and LUIGI BONAVINA

Anticancer Research March 2018, 38 (3) 1815-1820;
You have access
Does Patient-reported Dyspnea Reflect Thoracic Disease Characteristics in Patients with Incurable Cancer?
CARSTEN NIEDER, THOMAS A. KÄMPE and KIRSTEN ENGLJÄHRINGER

Anticancer Research February 2018, 38 (2) 901-904;

Main menu

User menu

Search

comorbidity

Pages